Qualitek Labs [QLL] vs Suraksha Diagnostic [SURAKSHA] Detailed Stock Comparison
Qualitek Labs
BSE
Loading...
Suraksha Diagnostic
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Qualitek Labs wins in 11 metrics, Suraksha Diagnostic wins in 5 metrics, with 0 ties. Qualitek Labs appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Qualitek Labs | Suraksha Diagnostic | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 45.40 | 49.97 | Qualitek Labs |
| Price-to-Book Ratio | 3.29 | 7.86 | Qualitek Labs |
| Debt-to-Equity Ratio | 37.74 | 42.28 | Qualitek Labs |
| PEG Ratio | N/A | 2.76 | N/A |
| EV/EBITDA | 22.03 | 25.33 | Qualitek Labs |
| Profit Margin (TTM) | 8.97% | 12.62% | Suraksha Diagnostic |
| Operating Margin (TTM) | 20.77% | 19.43% | Qualitek Labs |
| EBITDA Margin (TTM) | 20.77% | 19.43% | Qualitek Labs |
| Return on Equity | 12.27% | 15.14% | Suraksha Diagnostic |
| Return on Assets (TTM) | 7.19% | 9.54% | Suraksha Diagnostic |
| Free Cash Flow (TTM) | $-48.03M | $213.35M | Suraksha Diagnostic |
| 1-Year Return | -1.65% | -24.69% | Qualitek Labs |
| Price-to-Sales Ratio (TTM) | 4.56 | 6.30 | Qualitek Labs |
| Enterprise Value | $2.95B | $17.28B | Suraksha Diagnostic |
| EV/Revenue Ratio | 4.20 | 6.55 | Qualitek Labs |
| Gross Profit Margin (TTM) | N/A | 87.94% | N/A |
| Revenue per Share (TTM) | $79 | $51 | Qualitek Labs |
| Earnings per Share (Diluted) | $7.07 | $6.38 | Qualitek Labs |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Qualitek Labs vs Suraksha Diagnostic Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Qualitek Labs | 3.87% | 3.21% | 4.58% | 2.40% | 36.93% | -10.04% |
| Suraksha Diagnostic | -1.13% | 0.03% | 0.21% | -3.07% | 7.14% | -17.32% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Qualitek Labs | -1.65% | 113.18% | 113.18% | 113.18% | 113.18% | 113.18% |
| Suraksha Diagnostic | -24.69% | -24.69% | -24.69% | -24.69% | -24.69% | -24.69% |
Performance & Financial Health Analysis: Qualitek Labs vs Suraksha Diagnostic
| Metric | QLL | SURAKSHA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.20B | ₹16.60B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 7,760 | 39,095 |
| 90 Day Avg. Volume | 7,493 | 30,103 |
| Last Close | ₹330.00 | ₹314.25 |
| 52 Week Range | ₹215.05 - ₹375.00 | ₹231.00 - ₹449.00 |
| % from 52W High | -12.00% | -30.01% |
| All-Time High | ₹375.00 (Dec 23, 2024) | ₹449.00 (Dec 02, 2024) |
| % from All-Time High | -12.00% | -30.01% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | 0.21% |
| Quarterly Earnings Growth | N/A | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | 0.09% | 0.13% |
| Operating Margin (TTM) | 0.21% | 0.19% |
| Return on Equity (TTM) | 0.12% | 0.15% |
| Debt to Equity (MRQ) | 37.74 | 42.28 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹97.54 | ₹40.56 |
| Cash per Share (MRQ) | ₹1.99 | ₹3.86 |
| Operating Cash Flow (TTM) | ₹53.16M | ₹365.13M |
| Levered Free Cash Flow (TTM) | ₹76.84M | ₹318.24M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Qualitek Labs vs Suraksha Diagnostic
| Metric | QLL | SURAKSHA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 45.40 | 49.97 |
| Forward P/E | N/A | 33.62 |
| PEG Ratio | N/A | 2.76 |
| Price to Sales (TTM) | 4.56 | 6.30 |
| Price to Book (MRQ) | 3.29 | 7.86 |
| Market Capitalization | ||
| Market Capitalization | ₹3.20B | ₹16.60B |
| Enterprise Value | ₹2.95B | ₹17.28B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.20 | 6.55 |
| Enterprise to EBITDA | 22.03 | 25.33 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | ₹97.54 | ₹40.56 |
Financial Statements Comparison: Qualitek Labs vs Suraksha Diagnostic
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | QLL | SURAKSHA |
|---|---|---|
| Revenue/Sales | N/A | ₹725.86M |
| Cost of Goods Sold | N/A | ₹87.51M |
| Gross Profit | N/A | ₹638.36M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | ₹133.78M |
| EBITDA | N/A | ₹237.66M |
| Pre-Tax Income | N/A | ₹124.69M |
| Income Tax | N/A | ₹32.94M |
| Net Income (Profit) | N/A | ₹91.75M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | QLL | SURAKSHA |
|---|---|---|
| Cash & Equivalents | ₹51.74M | ₹22.47M |
| Total Current Assets | ₹426.08M | ₹471.53M |
| Total Current Liabilities | ₹325.84M | ₹427.17M |
| Long-Term Debt | ₹308.61M | ₹741.03M |
| Total Shareholders Equity | ₹927.82M | ₹2.10B |
| Retained Earnings | N/A | ₹1.54B |
| Property, Plant & Equipment | ₹589.98M | ₹1.38B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | QLL | SURAKSHA |
|---|---|---|
| Operating Cash Flow | N/A | ₹148.52M |
| Capital Expenditures | N/A | ₹-123.19M |
| Free Cash Flow | N/A | ₹64.63M |
| Debt Repayment | N/A | ₹-7.29M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | QLL | SURAKSHA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 7,760 | 39,095 |
| Average Daily Volume (90 Day) | 7,493 | 30,103 |
| Shares Outstanding | 9.98M | 52.08M |
| Float Shares | 711,777 | 21.54M |
| % Held by Insiders | 0.69% | 0.62% |
| % Held by Institutions | 0.00% | 0.23% |
Dividend Analysis & Yield Comparison: Qualitek Labs vs Suraksha Diagnostic
| Metric | QLL | SURAKSHA |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |